Status:
COMPLETED
Nalbuphine and Flurbiprofen for Oculoplastic Surgery
Lead Sponsor:
Sun Yat-sen University
Conditions:
Surgery
Anesthesia
Eligibility:
All Genders
16-75 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the postoperative pain and discomfort using flurbiprofen axetil or nalbuphine administration after oculoplastic surgery under general anesthesia.
Detailed Description
In this randomized controlled clinical trial, we evaluated the postoperative analgesic efficacy and adverse effects of flurbiprofen axetil combined with nalbuphine in patients undergoing oculoplastic ...
Eligibility Criteria
Inclusion
- Undergoing oculoplastic surgery
- age between 16 and 75 years
- American Society of Anesthesiologists (ASA) physical status of I-II
Exclusion
- serious coexisting disease
- body mass index (BMI) \<18.5 or \>35
- contraindications or previous adverse reactions to any of the drugs used
- females with a positive pregnancy test
- patients unable to cooperate
Key Trial Info
Start Date :
January 18 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2018
Estimated Enrollment :
330 Patients enrolled
Trial Details
Trial ID
NCT03422887
Start Date
January 18 2018
End Date
September 30 2018
Last Update
February 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sun Yat-sen University
Guangzhou, Guangdong, China, 510000